首页> 外文期刊>Hypertension research: Official journal of the Japanese Society of Hypertension >Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism.
【24h】

Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism.

机译:93例原发性醛固酮增多症患者中产生醛固酮的微腺瘤,大腺瘤和特发性醛固酮过多症的临床特征。

获取原文
获取原文并翻译 | 示例
           

摘要

Primary aldosteronism (PA) due to aldosterone-producing adenoma (APA) is a form of surgically curable secondary hypertension, and distinguishing APA from idiopathic hyperaldosteronism (IHA) is important for treatment. We made a differential diagnosis between APA and IHA using imaging tests such as adrenal CT and MRI as well as adrenal venous sampling (AVS) in all 93 cases of PA presenting at our institutions over the last decade. We identified 27 patients with aldosterone-producing microadenoma (APmicroA), all of whom could be diagnosed by AVS but not by the imaging tests. Then, we compared the clinical and roent-genological findings of these 27 patients with those of 42 patients with aldosterone-producing macroadenoma (APmacroA) and of 24 patients with IHA. Using surgically removed adrenal tissues, histopathological examinations and immunohistochemical analyses of steroidogenic enzymes were conducted. The findings for APmicroA were similar to those for APmacroA, except with respect to the diameter of the adrenal adenomas. Endocrinological and roentgenological findings for APmicroA were similar to those for IHA, but not to those for APmacroA. The rate of cure of hypertension was much greater in patients with APmicroA than in patients with APmacroA after the unilateral adrenalectomy (odds ratio, 4.0; p=0.028). In conclusion, it is important to accurately diagnose APmicroA, in which the laterality of the hyperproduction of aldosterone is only detectable by AVS, and to treat these patients by unilateral adrenalectomy in order to avoid long-term medical treatment and prevent hypertensive vascular complications.
机译:由产生醛固酮的腺瘤(APA)引起的原发性醛固酮增多症(PA)是可手术治愈的继发性高血压的一种形式,将APA与特发性醛固酮过多症(IHA)进行区分对于治疗很重要。在过去的十年中,我们使用了肾上腺CT和MRI等影像学检查以及肾上腺静脉采样(AVS)对APA和IHA进行了鉴别诊断,对我们机构中出现的所有93例PA进行了诊断。我们确定了27例产生醛固酮的微小腺瘤(APmicroA)患者,所有患者均可以通过AVS诊断,但不能通过影像学检查诊断。然后,我们比较了这27例患者与42例产生醛固酮的大腺瘤(APmacroA)和24例IHA患者的临床和X线检查结果。使用手术切除的肾上腺组织,进行了类固醇生成酶的组织病理学检查和免疫组化分析。除了在肾上腺腺瘤的直径方面,APmicroA的发现与APmacroA的发现相似。 APmicroA的内分泌学和伦琴学发现与IHA相似,但与APmacroA无关。单侧肾上腺切除术后,APmicroA患者的高血压治愈率远高于APmacroA患者(优势比,4.0; p = 0.028)。总之,重要的是准确诊断仅通过AVS可检测到醛固酮高产的偏侧性的APmicroA,并通过单侧肾上腺切除术治疗这些患者,以避免长期药物治疗和预防高血压血管并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号